Skip to content

How to get more Kybella patients: a plan for practices

A front desk team member at a med spa and aesthetic clinic handles a new patient call

Kybella (deoxycholic acid) for fat under the chin is often a cash-pay treatment, and its drug label says a lot about how it should be described. This guide is for practice owners, patient coordinators and front desk teams: what the FDA-approved labeling covers, which claims to avoid, and how to answer first calls so requests turn into booked consultations.

  1. SearchAn adult looks for care near them.
  2. Your pageWhat you treat, who sees them, one way to book.
  3. Call or formThey call or send a request.
  4. Front deskBooks the visit and never guesses a cause.
  5. Clinical teamThe clinician decides the plan.
How a new patient request reaches your practice.

1. Know what the drug is approved for

Kybella was approved by FDA in 2015. Its prescribing information says it is indicated “for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults”. Under limitations of use, it says Kybella “is not approved for the treatment of subcutaneous fat outside the submental region, and such use is not recommended”.

  • Describe the service as treatment for fat under the chin in adults, and say which product your clinicians use. FDA has also approved a generic deoxycholic acid, so do not call a generic “Kybella”.
  • Do not advertise it for jowls, arms, belly or other areas. The label warns that serious adverse reactions “have been reported following unapproved administration of KYBELLA outside the submental region”.
  • This is a drug, so “FDA approved” is the right term for the product. Do not stretch it to the whole treatment or to uses outside the label; see FDA approved vs FDA cleared.

2. Keep claims in line with the label

The label gives practices concrete facts to work with:

  • “Up to 6 treatments may be administered at intervals no less than 1 month apart”, and “the number of injections and the number of treatments should be tailored to the individual patient’s submental fat distribution and treatment goals”.
  • The most common adverse reactions (more than 20% of subjects) were injection site swelling, bruising, pain, numbness, redness and areas of hardness. In the pooled trials, 87% of Kybella patients had swelling and 70% had pain.
  • Some reactions lasted more than 30 days: numbness (42%), swelling (20%), pain (16%) and hardness (13%).
  • Warnings include nerve injury “manifested as an asymmetric smile or facial muscle weakness”, difficulty swallowing, and injection site hair loss, ulceration, necrosis, nodules and infection.

So avoid “one session”, “no downtime”, “painless”, “no side effects” and “risk-free”. Better wording: “one or more sessions at least a month apart”, “swelling and bruising are common” and “your clinician will explain the risks and aftercare”. Do not promise a set result.

3. Answer first-call questions honestly

  • How much does it cost? Give a clear price per treatment and say what it includes. Since more than one treatment may be needed, say so up front rather than quoting one session as the total.
  • How many treatments will I need? “It depends on the fat under your chin and your goals. The clinician will plan it at the consultation, with treatments at least a month apart.”
  • Is there downtime? “Swelling, bruising, soreness and numbness under the chin are common afterwards. The clinician will explain what to expect.”
  • Can you use it on my jowls or stomach? “It is approved only for fat under the chin.”

Leave medical screening to the clinician. The patient information asks patients to tell their provider about prior surgery or cosmetic treatment on the face, neck or chin, trouble swallowing, bleeding problems, pregnancy or breastfeeding, and blood thinners. Your intake form should ask about these, and the clinician decides. Use the new patient phone script for the rest of the call.

4. Plan bookings around swelling

Because swelling and bruising under the chin are common and some effects can last weeks, some patients may prefer to schedule around weddings, photos and trips. Mention this when booking, and leave room for treatments at least a month apart when the clinician plans more than one. The label tells patients to contact their provider about an uneven smile, facial weakness or trouble swallowing, so give them a number to call.

5. Price, package and follow up

Where MediLeadGen fits

MediLeadGen sends practices requests from people interested in cash-pay elective treatments. Each request goes to one practice only, with the person’s consent naming that practice, at a fixed price per delivered request.

See how it works for practices

Questions practices ask

How do we get more Kybella patients?

Answer requests quickly, give a clear price per treatment and say more than one may be needed, explain swelling and aftercare honestly, keep claims in line with the drug label, and book a consultation where the clinician can plan treatment.

What is Kybella approved for?

Its label says it is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. It is not approved for fat outside the submental region.

Can we advertise Kybella as having no downtime?

Avoid it. Swelling, bruising, pain and numbness were the most common reactions in the clinical trials, and some, such as numbness and swelling, lasted more than 30 days in a share of patients.

Is Kybella one session?

Not always. The label allows up to 6 treatments at least 1 month apart, tailored to the patient, so quote prices per treatment and let the clinician set the plan.

General information for practice teams, not legal or clinical advice. Check the labeling of the products you use, state rules and your advertising with counsel and your clinicians. Last reviewed October 2026.

More resources

All resources for practices